Lassen Therapeutics Announces Collaboration with Cedars Sinai Medical Center to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Lung Fibrosis March 25, 2021
Lassen Therapeutics Raises $31 Million to Pursue IL-11 Antibody for Cancer and Fibrosis June 18, 2020
